One abnormal value or vomiting after oral glucose tolerance test in pregnancy: incidence and impact on maternal-fetal outcomes

References

• American Diabetes Association. 15. Management of diabetes in pregnancy: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):1–6.
   PubMedGoogle Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–S38.
   PubMedGoogle Scholar
• Grupo Español de Diabetes y Embarazo (GEDE). Asistencia a la gestante con diabetes. Guía de práctica clínica actualizada en 2014 [assistance to pregnant woman with diabetes. 2014 updated clinical practice guideline]. Av Diabetol. 2015;31(2):45–59.
   Google Scholar
• Agarwal MM, Punnose J, Dhatt GS. Gestational diabetes: problems associated with the oral glucose tolerance test. Diabetes Res Clin Pract. 2004;63(1):73–74. doi: 10.1016/j.diabres.2003.08.005.
   PubMed Web of Science ®Google Scholar
• Fachnie JD, Whitehouse FW, McGrath Z. Vomiting during OGTT in third trimester of pregnancy. Diabetes Care. 1988;11(10):818. doi: 10.2337/diacare.11.10.818.
   PubMed Web of Science ®Google Scholar
• Greenberg VR, Lundsberg LS, Reddy UM, et al. Perinatal outcomes in obese women with one abnormal value on 3-hour oral glucose tolerance test. Am J Perinatol. 2022;39(5):464–472. doi: 10.1055/s-0041-1740005.
   PubMedGoogle Scholar
• Langer O, Brustman L, Anyaegbunam A, et al. The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy. Am J Obstet Gynecol. 1987;157(3):758–763. doi: 10.1016/s0002-9378(87)80045-5.
   PubMed Web of Science ®Google Scholar
• Roeckner JT, Sanchez-Ramos L, Jijon-Knupp R, et al. Single abnormal value on 3-hour oral glucose tolerance test during pregnancy is associated with adverse maternal and neonatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;215(3):287–297. doi: 10.1016/j.ajog.2016.04.040.
   PubMed Web of Science ®Google Scholar
• Kang S, Kim MH, Kim MY, et al. Progression to gestational diabetes mellitus in pregnant women with one abnormal value in repeated oral glucose tolerance tests. Diabetes Metab J. 2019;43(5):607–614. doi: 10.4093/dmj.2018.0159.
   PubMed Web of Science ®Google Scholar
• Mañé L, Flores-Le Roux JA, Benaiges D, et al. Role of First-Trimester HbA1c as a predictor of adverse obstetric outcomes in a multiethnic cohort. J Clin Endocrinol Metab. 2017;102(2):390–397.
   PubMed Web of Science ®Google Scholar
• Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National diabetes data group. Diabetes. 1979;28(12):1039–1057.
   PubMedGoogle Scholar
• Tranquilli AL, Brown MA, Zeeman GG, et al. The definition of severe and early-onset preeclampsia. Statements from the international society for the study of hypertension in pregnancy (ISSHP). Pregnancy Hypertens. 2013;3(1):44–47. doi: 10.1016/j.preghy.2012.11.001.
   PubMed Web of Science ®Google Scholar
• Martins JG, Biggio JR, Abuhamad A, Society for Maternal-Fetal Medicine (SMFM). Society for maternal-fetal medicine consult series #52: diagnosis and management of fetal growth restriction: (replaces clinical guideline number 3, april 2012). Am J Obstet Gynecol. 2020;223(4):B2–B17. doi: 10.1016/j.ajog.2020.05.010.
   PubMed Web of Science ®Google Scholar
• Di Cianni G, Seghieri G, Lencioni C, et al. Normal glucose tolerance and gestational diabetes mellitus: What is in between? Diabetes Care. 2007;30(7):1783–1788. doi: 10.2337/dc07-0119.
   PubMed Web of Science ®Google Scholar
• Corrado F, Benedetto AD, Cannata ML, et al. A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. J Matern Fetal Neonatal Med. 2009;22(7):597–601. doi: 10.1080/14767050902801801.
   PubMed Web of Science ®Google Scholar
• Forest JC, Massé J, Garrido-Russo M. Glucose tolerance test during pregnancy: the significance of one abnormal value. Clin Biochem. 1994;27(4):299–304. doi: 10.1016/0009-9120(94)00029-8.
   PubMed Web of Science ®Google Scholar
• Kim HS, Chang KH, Yang JI, et al. Clinical outcomes of pregnancy with one elevated glucose tolerance test value. Int J Gynaecol Obstet. 2002;78(2):131–138. doi: 10.1016/s0020-7292(02)00129-7.
   PubMed Web of Science ®Google Scholar
• Bevier WC, Fischer R, Jovanovic L. Treatment of women with an abnormal glucose challenge test (but a normal oral glucose tolerance test) decreases the prevalence of macrosomia. Am J Perinatol. 1999;16(6):269–275. doi: 10.1055/s-2007-993871.
   PubMed Web of Science ®Google Scholar
• Schwartz JG, Phillips WT, Blumhardt MR, et al. Use of a more physiologic oral glucose solution during screening for gestational diabetes mellitus. Am J Obstet Gynecol. 1994;171(3):685–691. doi: 10.1016/0002-9378(94)90082-5.
   PubMed Web of Science ®Google Scholar
• Moore TR, Hauguel-De Mouzon S, Catalano P. Diabetes in pregnancy. In: Resnik R, Lockwood CJ, Moore TR, Greene MF, Copel JA, Silver RM, editors. Creasy and Resnik’s maternal-fetal medicine: principles and practice. 8th ed. Philadelphia (PA): Elsevier; 2019.
   Google Scholar
• Rudge MV, Calderon IM, Ramos MD, et al. Perinatal outcome of pregnancies complicated by diabetes and by maternal daily hyperglycemia not related to diabetes. A retrospective 10-year analysis. Gynecol Obstet Invest. 2000;50(2):108–112. doi: 10.1159/000010293.
   PubMed Web of Science ®Google Scholar
• Negrato CA, Jovanovic L, Tambascia MA, et al. Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes. Diabetes Metab Res Rev. 2008;24(4):324–330. doi: 10.1002/dmrr.815.
   PubMed Web of Science ®Google Scholar
• Sermer M, Naylor CD, Gare DJ, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital gestational diabetes project. Am J Obstet Gynecol. 1995;173(1):146–156. doi: 10.1016/0002-9378(95)90183-3.
   PubMed Web of Science ®Google Scholar
• Simsek D, Akselim B, Altekin Y. Do patients with a single abnormal OGTT value need a globally admitted definition such as "borderline GDM"? Pregnancy outcomes of these women and the evaluation of new inflammatory markers. J Matern Fetal Neonatal Med. 2021;34(22):3782–3789. doi: 10.1080/14767058.2021.1946779.
   PubMed Web of Science ®Google Scholar
• Kung WJ, Kuo HY, Lee CH, et al. Association between gestational abnormal glucose tolerance and maternal-fetal outcomes. J Obstet Gynaecol Res. 2022;48(10):2505–2513. doi: 10.1111/jog.15350.
   PubMed Web of Science ®Google Scholar
• ACOG. Practice bulletin no. 190: gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):e49–64.
   PubMedGoogle Scholar